Welcome to LookChem.com Sign In|Join Free
  • or
5-Isoxazolecarboxylic acid, 3-(4-fluorophenyl)-4-[2-(methylthio)-4-pyrimidinyl]-, ethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

673451-63-3

Post Buying Request

673451-63-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

673451-63-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 673451-63-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,3,4,5 and 1 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 673451-63:
(8*6)+(7*7)+(6*3)+(5*4)+(4*5)+(3*1)+(2*6)+(1*3)=173
173 % 10 = 3
So 673451-63-3 is a valid CAS Registry Number.

673451-63-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 3-(4-fluorophenyl)-4-(2-(methylthio)pyrimidin-4-yl)isoxazole-5-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:673451-63-3 SDS

673451-63-3Downstream Products

673451-63-3Relevant academic research and scientific papers

ISOXAZOLES AND THEIR USE IN THE TREATMENT OF ISCHEMIC DISEASES

-

Page 10; 19-20, (2010/02/06)

The present invention provides a compound of formula I, or a pharmaceutically acceptable salt thereof. These compounds are useful for the treatment of neurological, neurodegenerative, ischemic and inflammatory disorders. Accordingly, the invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of neurological, neurodegenerative, ischemic and inflammatory disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 673451-63-3